Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: AIDS. 2021 Jul 1;35(8):1191–1199. doi: 10.1097/QAD.0000000000002857

Table 3.

Maternal Cobicistat Pharmacokinetic Parameters, Median (IQR)

Parameter Second Trimester n = 16 Third Trimester n = 26 Postpartum n = 19 Non-pregnant Adults with HIV1 GMR2 (90% CI) 2T/PP, n=12 GMR2 (90% CI) 3T/PP, n=18

AUC0–24 (μg*hr/mL) 4.46 (3.21, 5.69) 3.91 (3.15, 6.24) 8.52 (6.28, 11.39) 7.6 (± 3.7) 0.50 (0.36, 0.69)* 0.44 (0.35, 0.55)*
C0 (ng/mL) 4.1 (2.5, 10.8) 7.2 (2.5, 26.3) 28.5 (2.5, 171.0) - 0.28 (0.07, 1.10) 0.31 (0.09, 1.07)*
Cmax (ng/mL) 713.5 (525.0, 1050.5) 662.5 (497.0, 969.0) 1190.0 (838.0, 1300.0) 990 (± 300) 0.63 (0.51, 0.78)* 0.58 (0.48, 0.70)*
Tmax (hr) 2 (1, 3) 2 (1, 4) 2 (1, 4) - - -
C24 (ng/mL) 4.4 (2.45, 8.9) 5.5 (2.45, 8.8) 16.5 (7.2, 50.1) 0.03 (±0.1) 0.40 (0.23, 0.69)* 0.26 (0.16, 0.43)*
Cmin (ng/mL) 3.3 (2.45, 7.7) 5.5 (2.45, 8.8) 12.0 (7.2, 30.9) - 0.32 (0.20, 0.53)* 0.29 (0.16, 0.52)*
CL/F (L/hr) 33.67 (26.39, 46.68) 38.38 (24.05, 47.60) 17.61 (13.17, 23.88) - 2.01 (1.45, 2.77)* 2.27 (1.82, 2.83)*
T1/2 (hr) 2.87 (2.28, 3.43) 2.81 (2.27, 3.31) 3.43 (2.99, 4.53) - 0.86 (0.70, 1.06)* 0.75 (0.65, 0.86)*
*

p<0.10 compared to postpartum

1

Historical data from TYBOST® (cobicistat) package insert, represented as mean (±S.D.)

2

Paired comparisons

GMR, geometric mean ratio; 2T, second trimester, 3T, third trimester; PP, postpartum